IGC Pharma PFO exercises awards for 238,462 shares
IGC Pharma director and PFO Claudia Grimaldi exercised equity awards to acquire additional common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IGC Pharma director and PFO Claudia Grimaldi exercised equity awards to acquire additional common stock. On April 1, 2026, she converted 100,000 Restricted Stock Units into 100,000 shares of common stock and exercised options for 138,462 shares at an exercise price of $0.26 per share.
These exercises increased her direct holdings to 1,372,714 shares of common stock. The RSUs and options were originally granted in June 2023 and March 2024, respectively, and vest in equal installments over three years.
Insider Trade Summary
238,462 shares exercised/converted
Exercise
4 txns
Insider
GRIMALDI CLAUDIA
Role
PFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 100,000 | $0.00 | $0.00 |
| Exercise | Options | 138,462 | $0.00 | $0.00 |
| Exercise | Common Stock | 100,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 138,462 | $0.26 | $36K |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Options — 221,538 contracts (Direct);
Common Stock — 1,372,714 shares (Direct)
Footnotes (3)
- F1. On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.
- F2. On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting in March 2025. The exercise price is $0.26.
- F3. Each restricted stock unit represents a right to receive one share of IGC common stock.
Key Figures
RSUs exercised: 100,000 shares
Options exercised: 138,462 shares
Total shares acquired: 238,462 shares
+4 more
7 metrics
RSUs exercised
100,000 shares
Converted from Restricted Stock Units into common stock on April 1, 2026
Options exercised
138,462 shares
Options exercised into common stock on April 1, 2026
Total shares acquired
238,462 shares
Combined RSU and option exercises on April 1, 2026
Exercise price
$0.26 per share
Stock options granted March 13, 2024
Post-transaction holdings
1,372,714 shares
Common stock directly owned after exercises
RSU grant date
June 20, 2023
RSUs vest equally over three years starting March 2024
Option grant date
March 13, 2024
Options vest equally over three years starting March 2025
Key Terms
Restricted Stock Units, exercise price, vest, derivative security, +1 more
5 terms
Restricted Stock Units financial
"On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"The exercise price is $0.26."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"subject to vesting equally over three years starting on March 2024"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"Each restricted stock unit represents a right to receive one share of IGC common stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IGC (IGC) report for Claudia Grimaldi?
IGC reported that director and PFO Claudia Grimaldi exercised equity awards to acquire common stock. She converted 100,000 Restricted Stock Units and exercised options for 138,462 shares, increasing her direct stake in IGC Pharma’s common stock.
What is the exercise price of the IGC (IGC) options exercised by Claudia Grimaldi?
The options exercised by Claudia Grimaldi have an exercise price of $0.26 per share. These options were granted on March 13, 2024, and are scheduled to vest in three equal annual installments beginning in March 2025, according to the grant terms.
What are the vesting terms of the IGC (IGC) RSUs and options granted to Claudia Grimaldi?
The RSUs granted on June 20, 2023 vest in three equal annual installments starting March 2024. The options granted on March 13, 2024 vest equally over three years starting in March 2025, providing staged equity compensation over multiple years.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates